| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |